These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 17785674)

  • 1. Reduced cell anchorage may cause sarcolemma-specific collagen VI deficiency in Ullrich disease.
    Kawahara G; Okada M; Morone N; Ibarra CA; Nonaka I; Noguchi S; Hayashi YK; Nishino I
    Neurology; 2007 Sep; 69(10):1043-9. PubMed ID: 17785674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diminished binding of mutated collagen VI to the extracellular matrix surrounding myocytes.
    Kawahara G; Ogawa M; Okada M; Malicdan MC; Goto Y; Hayashi YK; Noguchi S; Nishino I
    Muscle Nerve; 2008 Sep; 38(3):1192-5. PubMed ID: 18642359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dominant collagen VI mutations are a common cause of Ullrich congenital muscular dystrophy.
    Baker NL; Mörgelin M; Peat R; Goemans N; North KN; Bateman JF; Lamandé SR
    Hum Mol Genet; 2005 Jan; 14(2):279-93. PubMed ID: 15563506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collagen VI status and clinical severity in Ullrich congenital muscular dystrophy: phenotype analysis of 11 families linked to the COL6 loci.
    Demir E; Ferreiro A; Sabatelli P; Allamand V; Makri S; Echenne B; Maraldi M; Merlini L; Topaloglu H; Guicheney P
    Neuropediatrics; 2004 Apr; 35(2):103-12. PubMed ID: 15127309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variable penetrance of COL6A1 null mutations: implications for prenatal diagnosis and genetic counselling in Ullrich congenital muscular dystrophy families.
    Peat RA; Baker NL; Jones KJ; North KN; Lamandé SR
    Neuromuscul Disord; 2007 Jul; 17(7):547-57. PubMed ID: 17537636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary collagen VI deficiency is the second most common congenital muscular dystrophy in Japan.
    Okada M; Kawahara G; Noguchi S; Sugie K; Murayama K; Nonaka I; Hayashi YK; Nishino I
    Neurology; 2007 Sep; 69(10):1035-42. PubMed ID: 17785673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscle interstitial fibroblasts are the main source of collagen VI synthesis in skeletal muscle: implications for congenital muscular dystrophy types Ullrich and Bethlem.
    Zou Y; Zhang RZ; Sabatelli P; Chu ML; Bönnemann CG
    J Neuropathol Exp Neurol; 2008 Feb; 67(2):144-54. PubMed ID: 18219255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Collagen VI-related muscle disorders].
    Higuchi I
    Brain Nerve; 2011 Nov; 63(11):1169-78. PubMed ID: 22068469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Collagenopathy (Ullrich congenital muscular dystrophy, Bethlem myopathy)].
    Higuchi I
    Rinsho Shinkeigaku; 2005 Nov; 45(11):935-7. PubMed ID: 16447767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibronectin receptor reduction in skin and fibroblasts of patients with Ullrich's disease.
    Hu J; Higuchi I; Shiraishi T; Suehara M; Niiyama T; Horikiri T; Uchida Y; Saito A; Osame M
    Muscle Nerve; 2002 Nov; 26(5):696-701. PubMed ID: 12402292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COL6A1 genomic deletions in Bethlem myopathy and Ullrich muscular dystrophy.
    Pepe G; Lucarini L; Zhang RZ; Pan TC; Giusti B; Quijano-Roy S; Gartioux C; Bushby KM; Guicheney P; Chu ML
    Ann Neurol; 2006 Jan; 59(1):190-5. PubMed ID: 16278855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative analysis of collagen VI production in muscle, skin and fibroblasts from 14 Ullrich congenital muscular dystrophy patients with dominant and recessive COL6A mutations.
    Jimenez-Mallebrera C; Maioli MA; Kim J; Brown SC; Feng L; Lampe AK; Bushby K; Hicks D; Flanigan KM; Bonnemann C; Sewry CA; Muntoni F
    Neuromuscul Disord; 2006 Oct; 16(9-10):571-82. PubMed ID: 16935502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal expression of proteoglycans in Ullrich's disease with collagen VI deficiency.
    Higashi K; Higuchi I; Niiyama T; Uchida Y; Shiraishi T; Hashiguchi A; Saito A; Horikiri T; Suehara M; Arimura K; Osame M
    Muscle Nerve; 2006 Jan; 33(1):120-6. PubMed ID: 16258947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ullrich disease: collagen VI deficiency: EM suggests a new basis for muscular weakness.
    Ishikawa H; Sugie K; Murayama K; Ito M; Minami N; Nishino I; Nonaka I
    Neurology; 2002 Sep; 59(6):920-3. PubMed ID: 12297580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal diagnosis of Ullrich congenital muscular dystrophy using haplotype analysis and collagen VI immunocytochemistry.
    Brockington M; Brown SC; Lampe A; Yuva Y; Feng L; Jimenez-Mallebrera C; Sewry CA; Flanigan KM; Bushby K; Muntoni F
    Prenat Diagn; 2004 Jun; 24(6):440-4. PubMed ID: 15229843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exon skipping mutations in collagen VI are common and are predictive for severity and inheritance.
    Lampe AK; Zou Y; Sudano D; O'Brien KK; Hicks D; Laval SH; Charlton R; Jimenez-Mallebrera C; Zhang RZ; Finkel RS; Tennekoon G; Schreiber G; van der Knaap MS; Marks H; Straub V; Flanigan KM; Chu ML; Muntoni F; Bushby KM; Bönnemann CG
    Hum Mutat; 2008 Jun; 29(6):809-22. PubMed ID: 18366090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allele-specific Gene Silencing of Mutant mRNA Restores Cellular Function in Ullrich Congenital Muscular Dystrophy Fibroblasts.
    Noguchi S; Ogawa M; Kawahara G; Malicdan MC; Nishino I
    Mol Ther Nucleic Acids; 2014 Jun; 3(6):e171. PubMed ID: 24959844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automated genomic sequence analysis of the three collagen VI genes: applications to Ullrich congenital muscular dystrophy and Bethlem myopathy.
    Lampe AK; Dunn DM; von Niederhausern AC; Hamil C; Aoyagi A; Laval SH; Marie SK; Chu ML; Swoboda K; Muntoni F; Bonnemann CG; Flanigan KM; Bushby KM; Weiss RB
    J Med Genet; 2005 Feb; 42(2):108-20. PubMed ID: 15689448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular consequences of dominant Bethlem myopathy collagen VI mutations.
    Baker NL; Mörgelin M; Pace RA; Peat RA; Adams NE; Gardner RJ; Rowland LP; Miller G; De Jonghe P; Ceulemans B; Hannibal MC; Edwards M; Thompson EM; Jacobson R; Quinlivan RC; Aftimos S; Kornberg AJ; North KN; Bateman JF; Lamandé SR
    Ann Neurol; 2007 Oct; 62(4):390-405. PubMed ID: 17886299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficiency of tenascin-X causes a decrease in the level of expression of type VI collagen.
    Minamitani T; Ariga H; Matsumoto K
    Exp Cell Res; 2004 Jul; 297(1):49-60. PubMed ID: 15194424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.